Skip to main content
Ilona Kickbusch

Ilona Kickbusch

German political scientist

Nov 4, 2026

13:03
Ilona, when you go to the council meeting and you look at the summit or the results or whatever, is there such a thing as you measure impact or how is that done?
13:16
Well, of course, there's the hard data that already Carsten referred to, you know, how many people came, what were the issues, the subjects that were discussed.
13:29
We do have very strict rules about gender equity.
13:34
So that's a really, really important thing.
13:38
And, you know, if I might say that as an aside, I find it quite astonishing, particularly reading all the critiques of the summit, that people already now take that matter of fact.
13:49
You know, 10 years ago, they were raging that there weren't enough women and I was fully on side.
13:56
But, you know, now that it's there and actually, and I want to really, really highlight that, that the summit prioritized issues of women's health at a point in time when other people are not willing to talk about sexual and reproductive health and rights anymore.

10 MINS LATER

24:13
And I think then they will also come to the summit.
30:11
Mm
30:11
...
30:11
the precautionary principle, and also, of course, in the European Union, uh, the policy principle is the precautionary principle.
30:20
But even here, and Matthew has alluded to it, I mean-The proof, the evidence, the research exists, only it's within the companies.
30:30
And that's what has been so important about this litigation.
30:33
I mean, some of the companies settled beforehand because they didn't want to share their evidence.
30:39
And, uh, so, uh, and I think it's also interesting to see the parallel, you sort of alluded to it, Matthew, that there have been whistleblowers, uh, just like in the tobacco case, that people have had the courage to say, "We will not look at this anymore, what, uh, what our company is doing, and we will share the evidence and the research." And, uh, so I think this, this approach, uh, is, is absolutely essential because also, you know, you look at research monies, et cetera, who's going to make available those enormous amounts of money that these companies are pouring into this research, just as the alcohol companies, the tobacco companies, and you name them, are doing in order to make sure that people buy and use their products.

9 MINS LATER

40:42
Ilona, what, what's your prescription for this?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.